Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Ring Energy
REI
$312M
| $259K | ﹤0.01% |
392,633
+301,033
| +329% | +$534K |
|
|
BCYC
3027
Bicycle Therapeutics
BCYC
$277M
| $257K | ﹤0.01% |
+18,800
| New | +$240K |
|
|
DYNT
3028
DELISTED
Dynatronics Corp
DYNT
| $257K | ﹤0.01% |
59,440
+49,420
| +493% | +$270K |
|
|
ELOX
3029
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $256K | ﹤0.01% |
3,270
-143
| -4% | -$23.3K |
|
|
VNE
3030
DELISTED
Veoneer, Inc.
VNE
| $256K | ﹤0.01% |
+35,000
| New | +$417K |
|
3031
Better Online Solutions
BOSC
$31.7M
| $254K | ﹤0.01% |
142,615
+1,211
| +0.9% | +$2.37K |
|
|
VBTX
3032
DELISTED
Veritex Holdings
VBTX
| $254K | ﹤0.01% |
+18,172
| New | +$437K |
|
3033
CareCloud
CCLD
$108M
| $253K | ﹤0.01% |
46,033
+20,833
| +83% | +$109K |
|
3034
Schwab US Mid-Cap ETF
SCHM
$15B
| $253K | ﹤0.01% |
18,000
-15,753
| -47% | -$288K |
|
3035
iShares Russell 2000 ETF
IWM
$82.5B
| $249K | ﹤0.01% |
+2,174
| New | +$324K |
|
3036
iShares National Muni Bond ETF
MUB
$45.4B
| $249K | ﹤0.01% |
2,200
-116,900
| -98% | -$13.3M |
|
|
WHWK
3037
Whitehawk Therapeutics
WHWK
$201M
| $248K | ﹤0.01% |
30,109
+2,967
| +11% | +$27.4K |
|
|
DSLV
3038
DELISTED
VelocitySharesTM 3x Inverse Silver ETN linked to the S&P GSCI Silver Inverse Index ER
DSLV
| $248K | ﹤0.01% |
+10,482
| New | +$200K |
|
3039
Illumina
ILMN
$30.2B
| $246K | ﹤0.01% |
+925
| New | +$259K |
|
3040
Palisade Bio
PALI
$368M
| $246K | ﹤0.01% |
83
+25
| +43% | +$108K |
|
3041
Taylor Devices
TAYD
$170M
| $246K | ﹤0.01% |
29,135
+3,035
| +12% | +$33K |
|
|
NYMX
3042
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $245K | ﹤0.01% |
104,700
+69,019
| +193% | +$194K |
|
3043
Pegasystems
PEGA
$5.23B
| $244K | ﹤0.01% |
+6,848
| New | +$287K |
|
3044
Duluth Holdings
DLTH
$157M
| $243K | ﹤0.01% |
+60,500
| New | +$450K |
|
|
IMMP
3045
Immutep
IMMP
$57.8M
| $243K | ﹤0.01% |
337,289
+238,968
| +243% | +$503K |
|
3046
Amplify Energy
AMPY
$160M
| $242K | ﹤0.01% |
+427,800
| New | +$1.87M |
|
3047
iShares Global Energy ETF
IXC
$2.75B
| $242K | ﹤0.01% |
+14,300
| New | +$357K |
|
3048
Limbach Holdings
LMB
$593M
| $242K | ﹤0.01% |
84,917
-37,800
| -31% | -$148K |
|
|
FLNT
3049
Fluent
FLNT
$104M
| $241K | ﹤0.01% |
34,318
-4,166
| -11% | -$56.9K |
|
|
ICON
3050
DELISTED
Iconix Brand Group, Inc.
ICON
| $240K | ﹤0.01% |
361,678
+5,300
| +1% | +$6.56K |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.